Hartoun Hartounian serves as Executive at BRAINSTORM CELL THERAPEUTICS INC., where they oversee executive responsibilities. Since joining the company, Hartoun Hartounian has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 24, 2024 involved receiving (via award) 30,000 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jun 24, 2024 | BCLI | $0 | Award | 30,000 | $N/A | Discretionary |
Hartoun Hartounian currently holds 30,000 shares of BRAINSTORM CELL THERAPEUTICS INC. (BCLI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Hartoun Hartounian has been a net neutral trader of BCLI stock. They have purchased $0 and sold $0 worth of shares.
Hartoun Hartounian's most recent insider trade was on Jun 24, 2024, when they sold 30,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted